TP53 and cervical cancer: Treatment with C-71980262 increased the p53-positive populations in SiHa and CaSki cells.<h4>Conclusion</h4>C-71980262 was identified as a novel lead molecule that could inhibit the HPV-16 E6 and increase p53 in cervical cancer cells.